Batra Y K, Jain K, Chari P, Dhillon M S, Shaheen B, Reddy G M
Department of Anaesthesiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Int J Clin Pharmacol Ther. 1999 Oct;37(10):519-23.
The administration of midazolam by centroneuraxis route has been shown to produce segmental antinociception. This midazolam analgesia was found to enhance the effects of local anesthetics given in combination epidurally without any adverse effects. The present study was designed to evaluate the post-operative analgesic effect of intrathecal midazolam-bupivacaine mixture in patients undergoing knee arthroscopy.
Thirty healthy patients scheduled for knee arthroscopy were divided into two groups to receive either midazolam-bupivacaine mixture (group M; n = 15) or bupivacaine alone (group B; n = 15) intrathecally. Level of sensory block, sedation score, assessment of pain using visual analogue score were recorded in both groups at regular time intervals. Time to block regression, recovery to ambulation and ability to void were recorded and noted before discharge.
A significantly higher VAS score was seen in group B patients as compared to the score observed in group M patients before discharge (p<0.05). All patients received rescue analgesia in group B at a mean duration of 258 +/-46.8 minutes whereas only one patient in group M required supplemental analgesia within this period. Time to regression of sensory analgesia to L5-S1 level was longer in group M (267+/-67.38) as compared to group B (229.8+/-41.4) (p<0.05). Blood pressure, heart rate, oxygen saturation and sedation score showed no differences between the groups. Neither motor block nor time to void were prolonged with the addition of midazolam to bupivacaine.
The results suggest that addition of midazolam to bupivacaine intrathecally provided better post-operative analgesia without any adverse effects.
经中枢神经轴途径给予咪达唑仑已被证明可产生节段性镇痛作用。已发现这种咪达唑仑镇痛作用可增强联合硬膜外给予局部麻醉药的效果,且无任何不良反应。本研究旨在评估鞘内注射咪达唑仑-布比卡因混合液对接受膝关节镜检查患者的术后镇痛效果。
将30例计划行膝关节镜检查的健康患者分为两组,分别鞘内注射咪达唑仑-布比卡因混合液(M组;n = 15)或单独注射布比卡因(B组;n = 15)。定期记录两组患者的感觉阻滞平面、镇静评分以及使用视觉模拟评分法评估的疼痛程度。记录并在出院前注明阻滞消退时间、恢复行走时间及排尿能力。
出院前,B组患者的视觉模拟评分显著高于M组患者(p<0.05)。B组所有患者均接受了平均持续时间为258±46.8分钟的补救镇痛,而在此期间M组仅1例患者需要补充镇痛。与B组(229.8±41.4)相比,M组感觉镇痛消退至L5-S1水平的时间更长(267±67.38)(p<0.05)。两组患者的血压、心率、血氧饱和度及镇静评分无差异。布比卡因中加入咪达唑仑既未延长运动阻滞时间,也未延长排尿时间。
结果表明,鞘内注射布比卡因时加入咪达唑仑可提供更好的术后镇痛效果,且无任何不良反应。